TYK Medicines Inc
HKEX:2410

Watchlist Manager
TYK Medicines Inc Logo
TYK Medicines Inc
HKEX:2410
Watchlist
Price: 14.3 HKD 4.53% Market Closed
Market Cap: 5.4B HKD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of TYK Medicines Inc.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
Not Available
Base Case Scenario
Compare TYK Medicines Inc to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TYK Medicines Inc?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
TYK Medicines Inc

Balance Sheet Decomposition
TYK Medicines Inc

Current Assets 483.3m
Cash & Short-Term Investments 392.9m
Other Current Assets 90.4m
Non-Current Assets 311.1m
Long-Term Investments 2m
PP&E 212.5m
Intangibles 59.6m
Other Non-Current Assets 37m
Current Liabilities 259.3m
Accounts Payable 14.1m
Accrued Liabilities 55.5m
Other Current Liabilities 189.7m
Non-Current Liabilities 178.2m
Long-Term Debt 13.4m
Other Non-Current Liabilities 164.8m
Efficiency

Free Cash Flow Analysis
TYK Medicines Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
TYK Medicines Inc

Revenue
107k CNY
Cost of Revenue
-93k CNY
Gross Profit
14k CNY
Operating Expenses
-489.7m CNY
Operating Income
-489.7m CNY
Other Expenses
-9.5m CNY
Net Income
-499.1m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

TYK Medicines Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional ROE
Exceptional 3Y Average ROE
Healthy Gross Margin
Sustainable 3Y Average Gross Margin
hidden
Profitability
Score

TYK Medicines Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

TYK Medicines Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Short-Term Solvency
hidden
Solvency
Score

TYK Medicines Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
TYK Medicines Inc

Wall Street analysts forecast TYK Medicines Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TYK Medicines Inc is 24.48 HKD with a low forecast of 24.24 HKD and a high forecast of 25.2 HKD.

Lowest
Price Target
24.24 HKD
70% Upside
Average
Price Target
24.48 HKD
71% Upside
Highest
Price Target
25.2 HKD
76% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

TYK Medicines Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TYK Medicines Inc is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y